Literature DB >> 34010240

Global, regional and national burden of lung cancer and its attributable risk factors in 204 countries and territories, 1990-2019.

Jingmin Yuan1, Yan Sun1, Xiang Bu1, Hui Ren1,2, Mingwei Chen1,2.   

Abstract

OBJECTIVE: To explore the lung cancer burden and related risk factors in groups of different sex, ages and levels of sociodemographic index (SDI) at global, regional and national levels.
METHODS: Using newly released GBD 2019 data, we explored the trends of lung cancer burden and its related risk factors in groups of different sex, ages and levels of SDI at global, regional and national levels. The Global Health Data Exchange query tool was used to obtain the data.
RESULTS: While lung cancer has an overall stable age-standardized incidence rate (ASIR), the death rate (ASDR) and disability-adjusted life-years (DALYs) rate (with even a trend of decline), it is still the number one malignant tumor. The ASIR and ASDR grew slowly in women worldwide. In 2019, High-income North America, East Asia and Central Europe ranked top three in ASIR, ASDR and age-standardized DALY rate, with growth in East Asia the highest. These three indicators were not in a single linear relation with SDI at a national level, and a peak appeared when SDI was about 0.8. The top three attributable risk factors to DALYs were smoking, particulate matter pollution and occupational carcinogens.
CONCLUSIONS: Given the high heterogeneity in lung cancer burden among different populations, decision-makers should understand local epidemiological characteristics of lung cancer in detail to formulate effective policies. Stricter tobacco control and improvement in lung cancer screening and treatment are imperative.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34010240     DOI: 10.1097/CEJ.0000000000000687

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  3 in total

1.  [Exosomal FZD10 derived from non-small cell lung cancer cells promotes angiogenesis of human umbilical venous endothelial cells in vitro].

Authors:  X Wu; R Zhan; D Cheng; L Chen; T Wang; X Tang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-09-20

2.  The Burden of Trachea, Bronchus, and Lung Cancer Attributable to Occupational Exposure From 1990 to 2019.

Authors:  Haifeng Li; Jingwen Guo; Hongsen Liang; Ting Zhang; Jinyu Zhang; Li Wei; Donglei Shi; Junhang Zhang; Zhaojun Wang
Journal:  Front Public Health       Date:  2022-06-17

3.  Exosomal epidermal growth factor receptor is involved in HPV-16 E7-induced epithelial-mesenchymal transition of non-small cell lung cancer cells: A driver of signaling in vivo?

Authors:  Zhiyuan Zhou; Xiaofeng Wu; Riming Zhan; Xiangyong Li; Dazhao Cheng; Li Chen; Tianyu Wang; Hua Yu; Guihong Zhang; Xudong Tang
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.875

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.